OraSure Technologies reported $70.39M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 282.22M 478K Mar/2026
AngioDynamics USD 41.57M 127K Sep/2025
Becton, Dickinson and Co. USD 370.59M 95.05M Jun/2026
Bio Techne USD 156.45M 703K Mar/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
Bruker USD 152.35M 130K Jun/2026
Charles River Laboratories USD 47.73M 439K Jun/2026
Danaher USD 702.9M 4.8M Jun/2026
Dentsply International USD 199.2M 1.1M Jun/2026
Dexcom USD 377.4M 8.5M Jun/2026
Illumina USD 151.3M 607K Jun/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
Intuitive Surgical USD 354.16M 1.01M Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
Mesa Laboratories USD 349.53M 3.53M Sep/2024
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Myriad Genetics USD 93.5M 400K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Quidel USD 68.1M 200K Mar/2026
Repligen USD 56.43M 28K Jun/2026
Revvity USD 111.63M 174K Jun/2026
STAAR Surgical USD 50.12M 343K Jun/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
Trinity Biotech USD 386.76M 1.57M Dec/2025
Waters USD 98.19M 20K Jun/2026